Intestinal dysbiosis and its associations in chronic diseases in children
DOI:
https://doi.org/10.33448/rsd-v13i8.46625Keywords:
Intestinal dysbiosis; Laxatives; Microbiome; Children's.Abstract
The human body is colonized by a variety of microorganisms essential for physiological functions, whose imbalance can result in intestinal dysbiosis, particularly significant in the gastrointestinal tract. During the first years of life, children undergo important changes in their intestinal microbiome. Chronic diseases, such as obesity and diabetes, affect both adults and children and may be associated with dysbiosis. In this integrative literature review of the literature, conducted in bibliographic repositories such as VHL, Medline and Lilacs, the objective was to identify studies that relate intestinal dysbiosis, in children, with chronic diseases, with an emphasis on prevalence and main impacts. The results highlight that dysbiosis is correlated with gastrointestinal symptoms in children with chronic diseases, with the diagnosis based on clinical signs. Factors such as malabsorption, laxative abuse and inadequate diet contribute to microbiome imbalance. Optimal treatment begins with dietary changes, such as glutamine supplementation, and may involve the use of specific probiotics and antibiotics, highlighting the importance of an integrated approach to managing gut health and preventing chronic disease. Therefore, it is concluded that the studies reviewed demonstrate that the intestinal microbiome plays a crucial role in the development and progression of several pediatric conditions, such as IBD, T1D, CD, respiratory and liver diseases, functional constipation and CF, highlighting the importance of intestinal dysbiosis and the therapeutic potential of probiotics, in addition to highlighting the need for more research to identify effective therapeutic and dietary strategies to improve children's health.
References
Andrade, M. D. S., & Lima, L. M. (2023). O impacto do aleitamento materno na microbiota intestinal infantil: uma revisão de literatura (Tese de Doutorado). (Unifametro).
Barros, J. A. (2009). A revisão bibliográfica – Uma dimensão fundamental para o planejamento da pesquisa. Instrumento, 11(2). Recuperado de: Vista do a Revisão Bibliográfica – Uma Dimensão Fundamental Para O Planejamento Da Pesquisa (ufjf.br).
Calleya, R. (2010). A ingestão de probióticos e prebióticos na prevenção e tratamento de doenças intestinais: uma revisão integrativa na área da nutrição (Trabalho de conclusão de curso). Universidade Estadual do Centro-Oeste (UNICENTRO), Departamento de Nutrição, Guarapuava.
Chen, L. W., Xu, J., Soh, S. E., Aris, I. M., Tint, M. T., Gluckman, P. D., Tan, K. H., Shek, L. P., Chong, Y. S., Yap, F., Godfrey, K. M., Gilbert, J. A., Karnani, N., & Lee, Y. S. (2020). Implication of gut microbioma in the association between infant antibiotic exposure and childhood obesity and adiposity accumulation. International Journal of Obesity (Lond), 44(7), 1508-1520. https://doi.org/10.1038/s41366-020-0572-0.
Costa Baptista, I. P., Accioly, E., & de Carvalho Padilha, P. (2013). Effect of the use of probiotics in the treatment of children with atopic dermatitis: A literature review. Nutr Hosp, 28(1), 16-26. https://doi.org/10.3305/nh.2013.28.1.6207.
Damasceno, S. S., Furtado, R. M., & Castro, L. C. (2016). Saúde da criança no Brasil: orientação da rede básica à Atenção Primária à Saúde. Ciência & Saúde Coletiva, 21, 2961-2973.
El Amouri, A., Snauwaert, E., Foulon, A., Vande Moortel, C., Van Dyck, M., Van Hoeck, K., Godefroid, N., Glorieux, G., Van Biesen, W., Vande Walle, J., Raes, A., & Eloot, S. (2021). Dietary fibre intake is associated with serum levels of uraemic toxins in children with chronic kidney disease. Toxins (Basel), 13(3), 225. https://doi.org/10.3390/toxins13030225
Esposito, S., Rigante, D., & Principi, N. (2014). Do children's upper respiratory tract infections benefit from probiotics? BMC Infectious Diseases, 14, 194. https://doi.org/10.1186/1471-2334-14-194
Flório, A. C. F. L., & Da Silva, M. C. (2024). Microbiota intestinal e sua relação com a obesidade–Uma revisão de literatura. Research, Society and Development, 13(6), e9213646120-e9213646120.
Korpela, K., Dikareva, E., Hanski, E., Kolho, K. L., de Vos, W. M., & Salonen, A. (2019). Cohort profile: Finnish Health and Early Life Microbioma (HELMi) longitudinal birth cohort. BMJ Open, 9(6), e028500. https://doi.org/10.1136/bmjopen-2018-028500.
Landman, C., & Quevrain, E. (2016). Gut microbioma: Description, role and pathophysiologic implications. Rev Med Interne, 37(6). Recuperado de [Microbioma intestinal: descrição, papel e implicações fisiopatológicas] - PubMed (nih.gov).
Lima Dantas, H. L., Oliveira, S. M., & Almeida, T. R. (2022). Como elaborar uma revisão integrativa: sistematização do método científico. Revista Recien-Revista Científica de Enfermagem, 12(37), 334-345.
Meij, T. G., de Groot, E. F., Eck, A., Budding, A. E., Kneepkens, C. M., Benninga, M. A., van Bodegraven, A. A., & Savelkoul, P. H. (2016). Characterization of microbioma in children with chronic functional constipation. PLoS One, 11(10), e0164731. https://doi.org/10.1371/journal.pone.0164731.
Moraes, F. J. P. (2017). Intestinal microbioma in Digestive Diseases. Arquivos de Gastroenterologia, 54(3). https://doi.org/10.1590/S0004-2803.201700000-31.
Nusbaum, D. J., Sun, F., Ren, J., Zhu, Z., Ramsy, N., Pervolarakis, N., Kunde, S., England, W., Gao, B., Fiehn, O., Michail, S., & Whiteson, K. (2018). Gut microbial and metabolomic profiles after fecal microbioma transplantation in pediatric ulcerative colitis patients. FEMS Microbiology Ecology, 94(9), fiy133. https://doi.org/10.1093/femsec/fiy133.
Pantoja, C. L., Costa, A. C. C., Costa, P. L. S., Andrade, M. A. H., Silva, V. V., & colaboradores. (2019). Diagnóstico e tratamento da disbiose: Revisão sistemática. Revista Eletrônica Acervo Saúde, 32(1). https://doi.org/10.25248/reas.e1368.2019.
Plaza-Díaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2018). Immune-mediated mechanisms of action of probiotics and synbiotics in treating pediatric intestinal diseases. Nutrients, 10(1), 42. https://doi.org/10.3390/nu10010042.
Price, C. E., Hampton, T. H., Valls, R. A., Barrack, K. E., O'Toole, G. A., Madan, J. C., & Coker, M. O. (2023). Development of the intestinal microbiome in cystic fibrosis in early life. mSphere, 8(4), e0004623. https://doi.org/10.1128/msphere.00046-23.
Ricciuto, A., Sherman, P. M., & Laxer, R. M. (2020). Gut microbioma in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis. Clinical Immunology, 215, 108415. https://doi.org/10.1016/j.clim.2020.108415.
Siddiqui, A., Haider, R., Aaqil, S. I., Vohra, L. I., Qamar, K., Jawed, A., Fatima, N., Adnan, A., Parikh, V., Ochani, S., & Hasibuzzaman, M. A. (2024). Probiotic formulations and gastrointestinal diseases in the pediatric population: A narrative review. Annals of Medicine and Surgery (Lond), 86(5), 2836-2847. https://doi.org/10.1097/MS9.0000000000002007.
Silva Escrivani, D., Barbosa, S. R., & Lima, A. C. (2023). Como a amamentação e a alimentação podem impactar na microbiota intestinal no desenvolver da criança. Research, Society and Development, 12(8), e11712842951-e11712842951.
Silva, W. E. A. (2023). A eficácia da modulação da microbiota intestinal no tratamento da desnutrição infantil (Trabalho de Conclusão de Curso). Universidade de Taubaté. Disponível em: http://repositorio.unitau.br/jspui/handle/20.500.11874/6803.
Souto, K. S. (2020). Evidências da disbiose intestinal em crianças menores de cinco anos (Monografia em Nutrição). Palmeira das Missões: Universidade Federal de Santa Maria. Recuperado de TCCG-NUT-2020-SOUTO.pdf (ufsm.br).
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkus, J., & Pyrzynska, B. (2021). Intestinal microbioma in common chronic inflammatory disorders affecting children. Frontiers in Immunology, 12, 642166. https://doi.org/10.3389/fimmu.2021.642166.
Verduci, E., Lassandro, C., Radaelli, G., & Soldati, L. (2015). Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: A novel approach? Journal of Translational Medicine, 13, 109. https://doi.org/10.1186/s12967-015-0471-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Carolina Salomon Santos; Yan Pires Alves; Marileia Chaves Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
